Reply to “Anti-TPO antibody, neutrophil, chronic urticaria, and omalizumab”
Roy Khalaf(McGill University), Moshe Ben-Shoshan(McGill University Health Centre), Elena Netchiporouk(McGill University Health Centre), John S. Sampalis(GDI Integrated Facility Services (Canada)), Michael Fein(McGill University Health Centre), Zainab Alsaffar(McGill University Health Centre), Abdulaziz S Alrafiaah(Majmaah University)
The Journal of Allergy and Clinical Immunology In Practice
December 1, 2025
Cited by 0
Related Papers
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
|Journal of the European Academy of Dermatology and Venereology|2023|107
Diagnosis and management of food allergies: new and emerging options: a systematic review
|Journal of Asthma and Allergy|2014|46
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada
|The Journal of Allergy and Clinical Immunology In Practice|2024|9
Long-Term Adherence and Risk of Allergic Reactions in Patients Who Attained Milk Oral Immunotherapy Maintenance
|The Journal of Allergy and Clinical Immunology In Practice|2024|5
Drug allergy
|Allergy Asthma and Clinical Immunology|2025|5